CCRCC
Clinical trials for CCRCC explained in plain language.
Never miss a new study
Get alerted when new CCRCC trials appear
Sign up with your email to follow new studies for CCRCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo tackles kidney cancer after immunotherapy fails
Disease control Not yet recruitingThis study tests a combination of two drugs, pembrolizumab and lenvatinib, in people with advanced kidney cancer (clear cell type) whose disease got worse after prior immunotherapy. About 108 adults will receive the treatment to see if it shrinks tumors or delays cancer growth. T…
Matched conditions: CCRCC
Phase: PHASE2 • Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
New PET scan may spot hidden kidney cancer after treatment
Diagnosis Not yet recruitingThis study tests whether a special PET scan using 89Zr-girentuximab can detect kidney cancer that remains or comes back after initial treatment. Ten adults with clear cell renal cell carcinoma will receive the scan before and after standard cryoablation. The goal is to see if the…
Matched conditions: CCRCC
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated May 26, 2026 11:59 UTC